These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4117291)

  • 1. Antigen-antibody crossed electrophoresis (Laurell) applied to the study of the antigenic structure of Candida albicans.
    Axelsen NH
    Infect Immun; 1971 Nov; 4(5):525-7. PubMed ID: 4117291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative immunoelectrophoretic methods as tools for a polyvalent approach to standardization in the immunochemistry of Candida albicans.
    Axelsen NH
    Infect Immun; 1973 Jun; 7(6):949-60. PubMed ID: 4577419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida albicans group A-specific soluble antigens demonstrated by quantitative immunoelectrophoresis.
    Guinet RM; Gabriel SM
    Infect Immun; 1980 Sep; 29(3):853-8. PubMed ID: 6159327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Candida antigens by crossed-immunoaffinoelectrophoresis.
    Bruneau SM; Guinet RM
    Sabouraudia; 1985 Apr; 23(2):107-18. PubMed ID: 2409611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative immunoelectrophoretic methods applied to the immunochemistry of Candida].
    Guinet R; Gabriel S
    C R Seances Soc Biol Fil; 1980; 174(3):325-34. PubMed ID: 6448676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of human Candida precipitins by quantitative immunoelectrophoresis: a model for analysis of complex microbial antigen-antibody systems.
    Axelsen NH
    Scand J Immunol; 1976; 5(3):177-90. PubMed ID: 775618
    [No Abstract]   [Full Text] [Related]  

  • 7. A novel antibody overlay technique for two-dimensional immunoelectrophoresis.
    Lebecq JC; Salhi SL; Bastide JM
    J Immunol Methods; 1984 Feb; 66(2):219-26. PubMed ID: 6361150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mannoproteins from a virulent Candida albicans strain and its derived, avirulent strain.
    Calderone RA; Wadsworth E
    Rev Infect Dis; 1988; 10 Suppl 2():S423-7. PubMed ID: 3055210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laurell crossed immunoelectrophoresis and affinity chromatography for the purification of a parasite antigen.
    Hillyer GV; Cervoni M
    J Immunol Methods; 1978; 20():385-90. PubMed ID: 418120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization with crossed immunoelectrophoresis of some antigens differentiating a virulent Candida albicans from its derived, avirulent strain.
    Calderone R; Wadsworth E
    Proc Soc Exp Biol Med; 1987 Jul; 185(3):325-34. PubMed ID: 2440054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans.
    Burnie JP; Matthews RC; Fox A; Tabaqchali S
    J Clin Pathol; 1985 Jun; 38(6):701-6. PubMed ID: 3891792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Candida sp. mannan antigen by indirect ELISA-inhibition. In vitro crossed reactivity among mannans obtained from C. albicans A, C. albicans B, and C. tropicalis.
    Garcia-de-Lomas J; Morales C; Grau MA; Mir A
    Mycopathologia; 1988 Jun; 102(3):175-8. PubMed ID: 3050526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antigen used in the detection of anti-Candida albicans antibodies.
    Garcia-de-Lomas J; Nogueira JM; Buesa FJ; Prat J; Mir A; Moreno F; Gea A
    Mycopathologia; 1985 Oct; 92(1):23-9. PubMed ID: 3906404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of antigenicity of Candida albicans growth phases to diagnosis of systemic candidiasis.
    Evans EG; Richardson MD; Odds FC; Holland KT
    Br Med J; 1973 Oct; 4(5884):86-7. PubMed ID: 4200829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoblot analyses of Candida albicans-associated antigens and antibodies in human sera.
    Manning-Zweerink M; Maloney CS; Mitchell TG; Weston H
    J Clin Microbiol; 1986 Jan; 23(1):46-52. PubMed ID: 2422198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls.
    Reiss E; Stone SH; Hasenclever HF
    Infect Immun; 1974 May; 9(5):881-90. PubMed ID: 4207516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protein and antigenic spectrum of different species of yeasts of the genus Candida].
    Mishneavskĭ NV; Tsinberg MB; Obvintsev VK
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):91-4. PubMed ID: 66829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of a major cytoplasmic antigen of Candida albicans.
    Greenfield RA; Jones JM
    Infect Immun; 1981 Nov; 34(2):469-77. PubMed ID: 7030960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of three monoclonal antibodies to Candida albicans proteins.
    Strockbine NA; Largen MT; Buckley HR
    Infect Immun; 1984 Mar; 43(3):1012-8. PubMed ID: 6365778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Candida albicans antigenic determinants by two-dimensional polyacrylamide gel electrophoresis and enhanced chemiluminescence.
    Barea PL; Calvo E; Rodriguez JA; Rementeria A; Calcedo R; Sevilla MJ; Pontón J; Hernando FL
    FEMS Immunol Med Microbiol; 1999 Apr; 23(4):343-54. PubMed ID: 10225294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.